close
Add to watchlist
SeraCare Life Sciences Inc (SRLS)
SeraCare Life Sciences, Inc., a global life sciences company, provides products and services to facilitate the discovery, development, and production of human diagnostics and therapeutics. It develops and manufactures biologically-based products and offers a range of related services, backed by expertise in virology, serology, immunology, and molecular biology. The company's portfolio includes diagnostic controls, plasma-derived reagents, and molecular biomarkers, as well as biobanking and contract research services. Its Diagnostic & Biopharmaceutical Products segment provides controls and panels used for the evaluation and quality control of infectious disease tests in hospital and clinical labs, and blood banks, as well as by in vitro diagnostic manufacturers; and reagents and bioprocessing products, including biological materials for use in the research, development, and manufacture of human and animal diagnostics, therapeutics, and vaccines. SeraCare's BioServices segment offers biobanking, sample processing, and testing services for research and clinical trials; and contract research services in molecular biology, virology, and biochemistry. The company was founded in 1984 and is headquartered in Milford, Massachusetts.
(login to add this stock to your watchlist or favorites)
Key Statistics
| Closing Price | 3.98 |
| Volume | 77294 |
| Volume Avg | 204190 |
| 52 Week High | 4.48 |
| 52 Week Low | 2.58 |
| PE | 36.00 |
| PE (group average) | N/A |
| EPS Year | 0.11 |
| EPS change Q/Q | -12.5% |
| EPS change Q/Q Yr ago | -36.36% |
| EPS change Q/Q next Q est | 40% |
| EPS change Y/Y | -9.09% |
| REV change Q/Q | 4.76% |
| REV change Q/Q Yr ago | -14.73% |
| EPS next Q est | 0.05 |
| EPS next Y est | 0.00 |
| Divident Annual | 0.00 |
| Dividend Yield | 0% |